BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35451632)

  • 1. Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion.
    James CA; Lewis PS; Moore MB; Wong K; Rader EK; Roberson PK; Ghaleb NA; Jensen HK; Pezeshkmehr AH; Stroud MH; Ashton DJ
    Pediatr Radiol; 2022 Nov; 52(12):2413-2420. PubMed ID: 35451632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
    James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
    Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation.
    Hanson SJ; Havens PL; Simpson PM; Nugent ML; Wells RG
    Pediatr Pulmonol; 2015 Dec; 50(12):1328-35. PubMed ID: 25847131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
    Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
    Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.
    Wells RG; Havens PL
    Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.
    Israel EN; Blackmer AB
    Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.
    Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R
    Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural tissue plasminogen activator and deoxyribonuclease administered concurrently and once daily for complex parapneumonic pleural effusion and empyema.
    Smith D; Shaw H; Ryder T
    Intern Med J; 2023 Dec; 53(12):2313-2318. PubMed ID: 37029951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study.
    Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF
    Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of practice in the management of parapneumonic effusion and empyema in children.
    Griffith D; Boal M; Rogers T
    J Pediatr Surg; 2018 Apr; 53(4):644-646. PubMed ID: 28781127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.
    Kheir F; Thakore S; Mehta H; Jantz M; Parikh M; Chee A; Kaphle U; Sisnega C; Fernandez-Bussy S; Majid A
    Ann Am Thorac Soc; 2020 Aug; 17(8):958-964. PubMed ID: 32421353
    [No Abstract]   [Full Text] [Related]  

  • 14. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Burfeind W
    Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study.
    Segerer FJ; Seeger K; Maier A; Hagemann C; Schoen C; van der Linden M; Streng A; Rose MA; Liese JG
    Pediatr Pulmonol; 2017 Apr; 52(4):540-547. PubMed ID: 27648553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
    Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
    Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
    Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
    Pediatrics; 2004 Mar; 113(3 Pt 1):e182-5. PubMed ID: 14993574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema.
    Cameron R; Davies HR
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
    Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
    Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.